Literature DB >> 26427896

Contralateral recurrence of tumefactive demyelination.

Mohammed Nazir Khan1, Mihail Guranda2, Marco Essig3.   

Abstract

Tumefactive demyelination refers to large focal demyelinating lesions in the brain, which can be mistaken for malignancy. In some patients, these lesions are monophasic with a self-limited course; however, other patients demonstrate recurrent disease with new tumefactive or non-tumefactive lesions, and a subsequent diagnosis of relapsing-remitting multiple sclerosis is not uncommon. Owing to the limited data available in the literature, many questions about the patterns and prognostic significance of recurrent tumefactive lesions remain unanswered. The current case report involves a patient who recovered from tumefactive demyelination and presented two years later with a new recurrent tumefactive lesion in the contralateral brain.
© The Author(s) 2015.

Entities:  

Keywords:  MRI; Tumefactive demyelination; brain; contralateral; multiple sclerosis; neuroinflammation; recurrence; tumefactive multiple sclerosis

Mesh:

Substances:

Year:  2015        PMID: 26427896      PMCID: PMC4757227          DOI: 10.1177/1971400915609798

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  15 in total

1.  Relapsing-remitting tumefactive multiple sclerosis.

Authors:  Stephen M Selkirk; Jiong Shi
Journal:  Mult Scler       Date:  2005-12       Impact factor: 6.312

2.  Case Series: tumefactive demyelinating lesions: a diagnostic challenge.

Authors:  Aria Fallah; Sarfaraz Banglawala; Shanil Ebrahim; John E Paulseth; Neilank K Jha
Journal:  Can J Surg       Date:  2010-02       Impact factor: 2.089

3.  Evolution and long term outcome in patients presenting with large demyelinating lesions as their first clinical event.

Authors:  Pandurang R Wattamwar; Neeraj N Baheti; Chandrasekharan Kesavadas; Muralidharan Nair; Ashalatha Radhakrishnan
Journal:  J Neurol Sci       Date:  2010-08-01       Impact factor: 3.181

4.  Tumefactive demyelination: clinical, imaging and follow-up observations in thirty-nine patients.

Authors:  M Nagappa; A B Taly; S Sinha; R D Bharath; A Mahadevan; P S Bindu; J S Saini; C Prasad; S K Shankar
Journal:  Acta Neurol Scand       Date:  2012-12-31       Impact factor: 3.209

Review 5.  Multiple sclerosis: pseudotumoral forms.

Authors:  G Comi
Journal:  Neurol Sci       Date:  2004-11       Impact factor: 3.307

6.  Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response.

Authors:  Christian L Seifert; Christiane Wegner; Till Sprenger; Martin S Weber; Wolfgang Brück; Bernhard Hemmer; Johann Sellner
Journal:  Mult Scler       Date:  2011-11-15       Impact factor: 6.312

7.  Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.

Authors:  A Altintas; B Petek; N Isik; M Terzi; F Bolukbasi; M Tavsanli; S Saip; C Boz; T Aydin; O Arici-Duz; F Ozer; A Siva
Journal:  Mult Scler       Date:  2012-03-14       Impact factor: 6.312

8.  Open-ring imaging sign: highly specific for atypical brain demyelination.

Authors:  J C Masdeu; C Quinto; C Olivera; M Tenner; D Leslie; P Visintainer
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

View more
  1 in total

1.  Demyelinating lesions behaving like aggressive tumours on advanced MRI techniques.

Authors:  Brainner Campos Barbosa; Edson Marchiori; Caio Leal Leidersnaider; Lara Brandao; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2019-01-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.